Eric Jacobsen MD has Hematology/oncology as his primary medical specialty. Their primary office is: 450 Brookline Ave in Boston, Massachusetts.
There is an additional office location, for a total of two, for Eric Jacobsen MD that can be viewed further down.
They're a part of the: Dana-farber Cancer Institute, Inc. medical group which has around 542 members. You can call their office at - to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Connecticut School Of Medicine and graduated in 1999 (around 25 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.
Eric Jacobsen MD
Dana-farber Cancer Institute, Inc.
450 Brookline Ave
Boston, Massachusetts 02215
-
Enter a starting address:
Medical School: University Of Connecticut School Of Medicine
Graduation Year: 1999
The Primary Medical Specialty for Eric Jacobsen MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 25
PAC (PECOS ID)#: 2567408354
NPI #: 1457321861
NPI Created On: 01/26/2006
NPI Last Updated Listed as: 07/08/2007
Primary Taxonomy Code: 207RH0003X
License Number:
219248
Listed Gender: Male
Forms of insurance accepted by include, but are not limited to:
They are listed as accepting new patients.
Languages spoken by staff include: English.
Services and Procedures include:
Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.
Payments Total: $3,548
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Record ID:: 783719025
Being Disputed:: No
Product Related: Yes
Payments Total: $350
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Record ID:: 843603669
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Oncology
Name of Drug #1: THYMOGLOBULIN
Open Associated Drug #1: 58468-0080-1
Drug or Biological: Biological
Product Category #2: Neurology
Name Of Drug #2:: LEMTRADA
Associated Drug #2: 58468-0200-1
Payments Total: $3,870
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Third party is a Charity:: No
Record ID:: 836325803
Being Disputed:: No
Product Related: Yes
Payments Total: $340
Number of Payments:: 2
Form of Payment: Cash or cash equivalent
Third party is a Charity:: No
Record ID:: 849117723
Being Disputed:: Yes
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: Lumoxiti
Open Associated Drug #1: 73380-4700-1
Payments Total: $2,223
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Third party is a Charity:: No
Record ID:: 789111569
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: Aliqopa
Open Associated Drug #1: 50419-385-01
1. Physicians Of Cape Cod Hospital
27 Park St
Hyannis, MA 02601
Group Members: 247
Phone: -
Enter a starting address:
330 Brookline Ave
Boston, MA
Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc
88 E Newton St
Boston, MA
Evans Medical Foundation Inc
1 Boston Medical Ctr Pl
Boston, MA
Evans Medical Foundation Inc
450 Brookline Ave
Boston, MA
Dana-farber Cancer Institute, Inc.
450 Brookline Ave
Boston, MA
Dana-farber Cancer Institute, Inc.
75 Francis St
Boston, MA
Dana-farber Cancer Institute, Inc.
20 Prospect St
Milford Ma 01757-3042
Dana-farber Cancer Institute, Inc.
Medical Oncology
450 Brookline Ave
Boston Ma 02215-5418
Dana-farber Cancer Institute, Inc.
Medical Oncology
75 Francis St
Boston Ma 02115-6110
Dana-farber Cancer Institute, Inc.
Internal Medicine
450 Brookline Ave
Boston Ma 02215-5418
Dana-farber Cancer Institute, Inc.
Internal Medicine
22 Patriot Pl
Foxborough Ma 02035-1375
Dana-farber Cancer Institute, Inc.
Medical Oncology
75 Francis St
Boston Ma 02115-6110
Dana-farber Cancer Institute, Inc.
Medical Oncology
View all 542 members of Dana-farber Cancer Institute, Inc. medical group